Abstract

Combining nanotechnology with glycobiology has triggered an exponential growth of research activities in the design of novel functional bionanomaterials (glyconanotechnology). More specifically, recent synthetic advances towards the tailored and versatile design of glycosylated nanoparticles namely glyconanoparticles, considered as synthetic mimetics of natural glycoconjugates, paved the way toward diverse biomedical applications. The accessibility of a wide variety of these structured nanosystems, in terms of shapes, sizes, and organized around stable nanoparticles have readily contributed to their development and applications in nanomedicine. In this context, glycosylated gold-nanoparticles (GNPs), glycosylated quantum dots (QDs), fullerenes, single-wall natotubes (SWNTs), and self-assembled glycononanoparticles using amphiphilic glycopolymers or glycodendrimers have received considerable attention to afford powerful imaging, therapeutic, and biodiagnostic devices. This review will provide an overview of the most recent syntheses and applications of glycodendrimers in glycoscience that have permitted to deepen our understanding of multivalent carbohydrate-protein interactions. Together with synthetic breast cancer vaccines, inhibitors of bacterial adhesions to host tissues including sensitive detection devices, these novel bionanomaterials are finding extensive relevance.

Highlights

  • Nanometric glycoconjugatesBiologically relevant sugar residues, linked to dendritic scaffolds and Nanoparticles (NPs), are becoming widely used as multivalent carbohydrate platforms toward biomedical applications

  • Intracellular delivery is predominantly effected by the NPs charges together with surface groups specialized toward cellular receptors necessary for cells’ nutrition or by one of the endocytic mechanism

  • Several studies have demonstrated that interactions mediated by the cancer-associated Thomsen-Friedenreich glycoantigen (TF-Ag) and the carbohydrate-binding protein galectin-3 play an important role in several rate-limiting steps of cancer metastasis

Read more

Summary

Nanometric glycoconjugates

Relevant sugar residues, linked to dendritic scaffolds and Nanoparticles (NPs), are becoming widely used as multivalent carbohydrate platforms toward biomedical applications. The accessibility of a wide variety of these structured nanosystems, in terms of shapes, sizes, and organized around stable nanoparticles have readily contributed to their development and applications in nanomedicine (Doane, Burda, 2012; Kottari et al, 2013). In this context, glycosylated gold-nanoparticles (GNPs), glycosylated quantum dots (QDs), fullerenes, single-wall natotubes (SWNTs), and self-assembled glyconanoparticles using amphiphilic glycopolymers or glycodendrimers have received considerable attention to afford powerful imaging, therapeutic, and biodiagnostic devices (Figure 1). The interactions are highly dependent on the sugar densities and multivalency has been frequently evoked to rationalize the detrimental pathophysiological outcome

Tumor associated carbohydrate antigens
GLYCODENDRIMER VACCINES
Compound Monomer
Glycodendrimers as potential antimetastatic agents
Gold glyconanoparticles as vaccines
GLYCODENDRIMERS AS BACTERIAL ANTIADHESINS
GOLD AND UPCONVERTING LANTHANIDE NANOPARTICLES
Relative potency
Findings
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.